Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service, (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) - Global Forecasts to 2028
Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service, (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) - Global Forecasts to 2028
Abstract
The global proteomics market size is projected to reach USD 72.9 billion by 2028 from 36.8 billion in 2023, at a CAGR of 14.6% during the forecast period. Factors such as increasing government funding for R&D projects to develop new therapeutics and protein-based drugs and the growing demand for personalized and efficient therapeutics, support the demand for proteomics products & services, and drive the market growth at a faster pace.
“The spectroscopy segment is likely to grow at the highest CAGR during the forecast period of 2023-2028.”
On the basis of instrumentation technologies, the proteomics market is broadly segmented into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, protein fractionation, and other technologies. The spectroscopy segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to the factor that the technique is widely employed in protein analysis to elucidate the protein structure (size, shape, secondary, or tertiary conformations), quantification, and interactions with molecules such as ligands, solutes, or other proteins.
“The biochips sub-segment is likely to grow at the highest CAGR during the forecast period of 2023-2028.”
On the basis of instrumentation technology protein microarray, the proteomics market is broadly segmented into biochips and microarray instruments. The biochips segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to the several advantages in proteomics research, including high-throughput analysis, multiplexing, sensitivity, specificity, reduced sample requirements, and automation.
“The pharmaceutical & biotechnological companies segment is likely to grow at the highest CAGR during the forecast period of 2023-2028.”
Based on end users, the proteomics market is segmented into hospitals, clinical laboratories, pharmaceutical companies, academic research laboratories, and other end users like CDMOs, and CROs. The pharmaceutical & biotechnological companies segment held a dominant share of the proteomics market, in 2022. The large share of this segment is attributed to the growing focus of pharma giants on core activities like increasing R&D for the discovery & development of new molecules. This is one of the major factors anticipated to project market growth.
“Asia Pacific region is likely to grow at a faster pace.”
The proteomics market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of the proteomics market. The dominance of the region is attributable to various factors such as the presence of leading players in the region coupled with the ongoing research activities of developing new targeted therapies. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the growing awareness of personalized therapeutics, rising government initiatives for generic medicines in the region, and the emergence of new market players in the proteomics market.
The primary interviews conducted for this report can be categorized as follows:
•By Respondent: Supply Side- 70%, and Demand Side - 30%
•By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
•By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%
Lists of Companies Profiled in the Report:
•Thermo Fisher Scientific, Inc. (US)
•Agilent Technologies, Inc. (US)
•Merck KGaA (Germany)
•Danaher Corporation (US)
•Waters Corporation (US)
•Bio-Rad Laboratories, Inc. (US)
•Bruker Corporation (US)
•PerkinElmer Inc. (US)
•Shimadzu Corporation (Japan)
•Illumina, Inc. (US)
•Promega Corporation (US)
•Eurofins Scientific (Luxembourg)
•QIAGEN N.V. (Germany)
•Charles River Laboratories (US)
•Protagene Protein Services (Germany)
•Creative Proteomics (US)
•HORIBA Corporation (Japan)
•Sengenics (Singapore)
•Biomax Informatics AG (Germany)
•WuXi NextCode (China)
•FIOS Genomics (UK)
•Genewiz (US)
•Medgenome Labs (India)
•Biognosys AG (Switzerland)
•Macrogen Inc. (South Korea)
Research Coverage:
This report provides a detailed picture of the proteomics market. It aims at estimating the size and future growth potential of the market across different segments, such as instrumentation technologies, reagents, software & services, application, end user, and regions. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall proteomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
•Analysis of key drivers (Increasing demand for personalized medicines for clinical practices, Rising incidences of chronic diseases among geriatric population, Increased investments in research and greater adoption of proteomics in drug discovery, Technological advancements in proteomics), restraints (High costs of proteomics instruments and technologies, Lack of standardization in proteomics workflow among research groups), opportunities (High growth opportunities for proteomics research in emerging countries, Growing prominence of nano proteomics in biological processes), and challenges (Low biomarker discovery to approval ratio in proteomics research, Lack of data management/handling in proteomics research) influencing the growth of proteomics market.
•Product & Service Development/Innovation: Detailed insights on newly launched products, and technological assessment of the proteomics market.
•Market Development: Comprehensive information about lucrative markets – the report analyses the proteomics market across varied regions.
•Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the proteomics market.
•Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of leading players like Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), and Waters Corporation (US) and among others in the proteomics market.
Content
Table of Contents
1INTRODUCTION70
1.1STUDY OBJECTIVES70
1.2MARKET DEFINITION AND SCOPE70
1.2.1INCLUSIONS AND EXCLUSIONS71
1.2.2MARKETS COVERED72
1.2.3YEARS CONSIDERED73
1.3CURRENCY CONSIDERED73
1.4STAKEHOLDERS73
1.5RESEARCH LIMITATIONS74
1.6SUMMARY OF CHANGES74
1.7RECESSION IMPACT75
2RESEARCH METHODOLOGY76
2.1RESEARCH DATA76
FIGURE 1RESEARCH DESIGN76
2.1.1SECONDARY DATA77
2.1.2PRIMARY DATA78
FIGURE 2PROTEOMICS MARKET: BREAKDOWN OF PRIMARIES78
2.2MARKET SIZE ESTIMATION79
FIGURE 3PROTEOMICS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 202279
FIGURE 4MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 202280
FIGURE 5ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 202280
2.2.1INSIGHTS FROM PRIMARIES82
FIGURE 6MARKET VALIDATION FROM PRIMARY EXPERTS82
2.2.2SEGMENT ASSESSMENT (BY PRODUCT, SOFTWARE & SERVICE, AND END USER)82
FIGURE 7MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH82
2.3GROWTH RATE ASSUMPTIONS83
FIGURE 8PROTEOMICS MARKET: CAGR PROJECTIONS, 2023–202884
FIGURE 9PROTEOMICS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES84
2.4MARKET BREAKDOWN AND DATA TRIANGULATION85
FIGURE 10DATA TRIANGULATION METHODOLOGY85
2.5STUDY ASSUMPTIONS86
2.6RISK ANALYSIS86
2.7IMPACT OF ECONOMIC RECESSION ON PROTEOMICS MARKET86
TABLE 1GLOBAL INFLATION RATE PROJECTIONS, 2024–2027 (% GROWTH)87
TABLE 2US HEALTH EXPENDITURE, 2019–2027 (USD MILLION)87
TABLE 3US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)87
3EXECUTIVE SUMMARY88
FIGURE 11PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2023 VS. 2028 (USD MILLION)88
FIGURE 12PROTEOMICS MARKET, BY REAGENT, 2023 VS. 2028 (USD MILLION)89
FIGURE 13PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2023 VS. 2028 (USD MILLION)90
FIGURE 14PROTEOMICS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)90
FIGURE 15PROTEOMICS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)91
FIGURE 16GEOGRAPHICAL SNAPSHOT OF PROTEOMICS MARKET92
4PREMIUM INSIGHTS93
4.1OVERVIEW OF PROTEOMICS MARKET93
FIGURE 17RISING INVESTMENTS IN PHARMACEUTICAL R&D TO DRIVE MARKET93
4.2NORTH AMERICA: PROTEOMICS MARKET SHARE, BY APPLICATION AND COUNTRY (2022)94
FIGURE 18CLINICAL DIAGNOSTICS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PROTEOMICS MARKET IN 202294
4.3ELECTROPHORESIS MARKET SHARE, BY TYPE, 2023 VS. 2028 (USD MILLION)95
FIGURE 19GEL ELECTROPHORESIS TO DOMINATE MARKET IN 202895
4.4PROTEOMICS MARKET SHARE, BY END USER (2022)95
FIGURE 20PHARMACEUTICAL COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 202295
4.5PROTEOMICS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES96
FIGURE 21ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN PROTEOMICS MARKET DURING STUDY PERIOD96
5MARKET OVERVIEW97
5.1INTRODUCTION97
5.2MARKET DYNAMICS97
FIGURE 22PROTEOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES97
TABLE 4PROTEOMICS MARKET: IMPACT ANALYSIS98
5.2.1DRIVERS98
5.2.1.1Increasing demand for personalized medicines for clinical practices98
FIGURE 23PERSONALIZED MEDICINES APPROVED BY FDA, 2015–202299
5.2.1.2Rising incidences of chronic diseases among geriatric population100
5.2.1.3Increased investments in research and greater adoption of proteomics in drug discovery100
FIGURE 24GLOBAL SPENDING ON PHARMACEUTICAL R&D, 2015–2028 (USD BILLION)101
5.2.1.4Technological advancements in proteomics101
5.2.2RESTRAINTS102
5.2.2.1High costs of proteomics instruments and technologies102
5.2.2.2Lack of standardization in proteomics workflow among research groups103
5.2.3OPPORTUNITIES103
5.2.3.1High growth opportunities for proteomics research in emerging countries103
5.2.3.2Growing prominence of nano proteomics in biological processes104
5.2.4CHALLENGES105
5.2.4.1Low biomarker discovery to approval ratio in proteomics research105
5.2.4.2Lack of data management/handling in proteomics research105
5.3VALUE CHAIN ANALYSIS106
FIGURE 25VALUE CHAIN ANALYSIS: MANUFACTURING AND DISTRIBUTION PHASES PROVIDE MAXIMUM VALUE106
5.4SUPPLY CHAIN ANALYSIS107
FIGURE 26PROTEOMICS MARKET: SUPPLY CHAIN ANALYSIS107
5.5ECOSYSTEM ANALYSIS108
FIGURE 27ECOSYSTEM ANALYSIS: PROTEOMICS MARKET108
TABLE 5PROTEOMICS MARKET: ROLE IN ECOSYSTEM109
5.6PORTER’S FIVE FORCES ANALYSIS109
TABLE 6PROTEOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS109
5.6.1THREAT OF NEW ENTRANTS109
5.6.2THREAT OF SUBSTITUTES110
5.6.3BARGAINING POWER OF SUPPLIERS110
5.6.4BARGAINING POWER OF BUYERS110
5.6.5INTENSITY OF COMPETITIVE RIVALRY110
5.7PATENT ANALYSIS111
5.8PRICING ANALYSIS111
TABLE 7AVERAGE SELLING PRICE OF PROTEOMICS PRODUCTS (2022)111
TABLE 8PERKINELMER: SELLING PRICE OF VARIOUS PRODUCTS/SERVICES112
TABLE 9MERCK: SELLING PRICE OF VARIOUS PRODUCTS/SERVICES112
5.9TECHNOLOGY ANALYSIS113
TABLE 10COMPARISON OF MODERN PROTEOMICS ANALYSIS METHODS113
TABLE 11COMMONLY USED BIOINFORMATICS TOOLS IN PROTEOMICS114
TABLE 12TECHNOLOGIES LAUNCHED RECENTLY IN PROTEOMICS114
5.10REGULATORY ANALYSIS115
5.10.1REGULATIONS FOR PRODUCTS DEVELOPED USING PROTEOMICS TECHNIQUES115
TABLE 13KEY REGULATORY GUIDELINES FOR PROTEOMICS PRODUCTS116
5.10.2REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS116
TABLE 14NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS116
TABLE 15EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS117
TABLE 16ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS117
5.11KEY CONFERENCES AND EVENTS IN 2023118
TABLE 17PROTEOMICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023118
5.12KEY STAKEHOLDERS AND BUYING CRITERIA119
5.12.1KEY STAKEHOLDERS IN BUYING PROCESS119
FIGURE 28INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR APPLICATIONS119
TABLE 18INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR APPLICATIONS119
5.12.2BUYING CRITERIA119
FIGURE 29KEY BUYING CRITERIA FOR END USERS119
5.13TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES120
5.14TRADE ANALYSIS120
5.14.1TRADE ANALYSIS FOR ELECTROPHORESIS AND CHROMATOGRAPHY INSTRUMENTS120
TABLE 19IMPORT DATA FOR ELECTROPHORESIS AND CHROMATOGRAPHY INSTRUMENTS, BY COUNTRY, 2017–2021 (USD MILLION)120
5.14.2TRADE ANALYSIS FOR DIAGNOSTICS AND LABORATORY REAGENTS121
TABLE 20IMPORT DATA FOR DIAGNOSTICS AND CLINICAL REAGENTS, BY COUNTRY, 2017–2021 (USD MILLION)121
TABLE 21EXPORT DATA FOR DIAGNOSTICS AND CLINICAL REAGENTS, BY COUNTRY, 2017–2021 (TONS)121
5.14.3TRADE ANALYSIS FOR IMMUNOASSAYS121
TABLE 22IMPORT DATA FOR HS CODE 902750, BY COUNTRY, 2017–2021 (USD MILLION)121
6PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY122
6.1INTRODUCTION123
6.1.1PRICING ANALYSIS123
TABLE 23AVERAGE SELLING PRICE OF PRODUCTS AND SERVICES, 2022 (USD)123
TABLE 24PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)124
6.2SPECTROSCOPY124
TABLE 25PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)125
TABLE 26PROTEOMICS MARKET FOR SPECTROSCOPY, BY REGION, 2021–2028 (USD MILLION)125
TABLE 27NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)126
TABLE 28EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)126
TABLE 29ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)127
TABLE 30LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)127
6.2.1MASS SPECTROSCOPY128
6.2.1.1High specificity of mass spectroscopy to boost market128
TABLE 31MASS SPECTROSCOPY MARKET, BY REGION, 2021–2028 (USD MILLION)129
TABLE 32NORTH AMERICA: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)129
TABLE 33EUROPE: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)130
TABLE 34ASIA PACIFIC: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)130
TABLE 35LATIN AMERICA: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)131
6.2.2NMR SPECTROSCOPY131
6.2.2.1NMR experiments to evaluate physical, chemical, electronic, and structural information of proteins131
TABLE 36NMR SPECTROSCOPY MARKET, BY REGION, 2021–2028 (USD MILLION)132
TABLE 37NORTH AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)132
TABLE 38EUROPE: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)133
TABLE 39ASIA PACIFIC: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)133
TABLE 40LATIN AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)134
6.2.3CD SPECTROSCOPY134
6.2.3.1CD spectroscopy to examine changes in secondary structures of protein in response to environmental conditions134
TABLE 41CD SPECTROSCOPY MARKET, BY REGION, 2021–2028 (USD MILLION)135
TABLE 42NORTH AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)135
TABLE 43EUROPE: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)136
TABLE 44ASIA PACIFIC: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)136
TABLE 45LATIN AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)137
6.3CHROMATOGRAPHY137
TABLE 46PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)138
TABLE 47PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY REGION, 2021–2028 (USD MILLION)138
TABLE 48NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)139
TABLE 49EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)139
TABLE 50ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)140
TABLE 51LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)140
6.3.1HPLC141
6.3.1.1Growing biopharmaceutical industry and increasing investments in life science research141
TABLE 52HPLC MARKET, BY REGION, 2021–2028 (USD MILLION)142
TABLE 53NORTH AMERICA: HPLC MARKET, BY COUNTRY, 2021–2028 (USD MILLION)142
TABLE 54EUROPE: HPLC MARKET, BY COUNTRY, 2021–2028 (USD MILLION)143
TABLE 55ASIA PACIFIC: HPLC MARKET, BY COUNTRY, 2021–2028 (USD MILLION)143
TABLE 56LATIN AMERICA: HPLC MARKET, BY COUNTRY, 2021–2028 (USD MILLION)144
6.3.2ION CHROMATOGRAPHY144
6.3.2.1Ion chromatography to be most significant chromatographic technique for separation and purification of proteins144
TABLE 57ION CHROMATOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)145
TABLE 58NORTH AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)145
TABLE 59EUROPE: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)146
TABLE 60ASIA PACIFIC: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)146
TABLE 61LATIN AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)147
6.3.3AFFINITY CHROMATOGRAPHY147
6.3.3.1Affinity chromatography to quantify protein expression using isotope-coded affinity tags147
TABLE 62AFFINITY CHROMATOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)148
TABLE 63NORTH AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)148
TABLE 64EUROPE: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)149
TABLE 65ASIA PACIFIC: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)149
TABLE 66LATIN AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)150
6.3.4SUPERCRITICAL FLUID CHROMATOGRAPHY150
6.3.4.1Supercritical fluid chromatography to separate complex protein mixtures with high efficiency and speed150
TABLE 67SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)151
TABLE 68NORTH AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)151
TABLE 69EUROPE: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)152
TABLE 70ASIA PACIFIC: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)152
TABLE 71LATIN AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)153
6.4ELECTROPHORESIS153
TABLE 72PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)154
TABLE 73PROTEOMICS MARKET FOR ELECTROPHORESIS, BY REGION, 2021–2028 (USD MILLION)154
TABLE 74NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION)155
TABLE 75EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION)155
TABLE 76ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION)156
TABLE 77LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION)156
6.4.1GEL ELECTROPHORESIS157
6.4.1.1Increasing demand for gel electrophoresis in proteomics research and personalized medicine157
TABLE 78GEL ELECTROPHORESIS MARKET, BY REGION, 2021–2028 (USD MILLION)157
TABLE 79NORTH AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)158
TABLE 80EUROPE: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)158
TABLE 81ASIA PACIFIC: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)159
TABLE 82LATIN AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)159
6.4.2CAPILLARY ELECTROPHORESIS160
6.4.2.1Rise in applications of capillary electrophoresis in therapeutics and drug discovery160
TABLE 83CAPILLARY ELECTROPHORESIS MARKET, BY REGION, 2021–2028 (USD MILLION)161
TABLE 84NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)161
TABLE 85EUROPE: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)162
TABLE 86ASIA PACIFIC: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)162
TABLE 87LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)163
6.5PROTEIN MICROARRAYS163
TABLE 88PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)164
TABLE 89PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY REGION, 2021–2028 (USD MILLION)164
TABLE 90NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)165
TABLE 91EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)165
TABLE 92ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)166
TABLE 93LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)166
6.5.1BIOCHIPS166
TABLE 94BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)167
TABLE 95BIOCHIPS MARKET, BY REGION, 2021–2028 (USD MILLION)167
TABLE 96NORTH AMERICA: BIOCHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)168
TABLE 97EUROPE: BIOCHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)168
TABLE 98ASIA PACIFIC: BIOCHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)169
TABLE 99LATIN AMERICA: BIOCHIPS MARKET, BY REGION, 2021–2028 (USD MILLION)169
6.5.1.1Lab-on-chips169
6.5.1.1.1Rising applications of lab-on-chips in microfabrication and nanotechnology development169
TABLE 100LAB-ON-CHIPS MARKET, BY REGION, 2021–2028 (USD MILLION)170
TABLE 101NORTH AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)171
TABLE 102EUROPE: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)171
TABLE 103ASIA PACIFIC: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)172
TABLE 104LATIN AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)172
6.5.1.2Protein chips173
6.5.1.2.1Competitive advantage over conventional protein analysis tools173
TABLE 105PROTEIN CHIPS MARKET, BY REGION, 2021–2028 (USD MILLION)174
TABLE 106NORTH AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)174
TABLE 107EUROPE: PROTEIN CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)175
TABLE 108ASIA PACIFIC: PROTEIN CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)175
TABLE 109LATIN AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)176
6.5.2MICROARRAY INSTRUMENTS176
TABLE 110MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)177
TABLE 111MICROARRAY INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)177
TABLE 112NORTH AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)178
TABLE 113EUROPE: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)178
TABLE 114ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)179
TABLE 115LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)179
6.5.2.1Integrated systems180
6.5.2.1.1Integrated systems to enable high-throughput and reproducible analysis of large numbers of proteins180
TABLE 116INTEGRATED SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)180
TABLE 117NORTH AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)181
TABLE 118EUROPE: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)181
TABLE 119ASIA PACIFIC: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)182
TABLE 120LATIN AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)182
6.5.2.2Microarray scanners183
6.5.2.2.1Microarray scanners to provide high-quality analysis and cost efficiency183
TABLE 121MICROARRAY SCANNERS MARKET, BY REGION, 2021–2028 (USD MILLION)183
TABLE 122NORTH AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)184
TABLE 123EUROPE: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)184
TABLE 124ASIA PACIFIC: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)185
TABLE 125LATIN AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)185
6.5.2.3Arrayers186
6.5.2.3.1Technological advancements to make microarray spotters ideal for large-scale arraying projects186
TABLE 126ARRAYERS MARKET, BY REGION, 2021–2028 (USD MILLION)186
TABLE 127NORTH AMERICA: ARRAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)186
TABLE 128EUROPE: ARRAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)187
TABLE 129ASIA PACIFIC: ARRAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)187
TABLE 130LATIN AMERICA: ARRAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)188
6.6X-RAY CRYSTALLOGRAPHY188
6.6.1INCREASED NEED FOR HIGH-RESOLUTION INFORMATION ON PROTEIN STRUCTURES WITH X-RAY CRYSTALLOGRAPHY TO AID MARKET188
TABLE 131PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY REGION, 2021–2028 (USD MILLION)189
TABLE 132NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)189
TABLE 133EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)190
TABLE 134ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)190
TABLE 135LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)191
6.7SURFACE PLASMON RESONANCE191
6.7.1ABILITY TO MEASURE BINDING AFFINITIES AND KINETICS OF COMPLEXES TO PROPEL MARKET191
TABLE 136PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY REGION, 2021–2028 (USD MILLION)192
TABLE 137NORTH AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION)192
TABLE 138EUROPE: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION)193
TABLE 139ASIA PACIFIC: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION)193
TABLE 140LATIN AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION)194
6.8PROTEIN FRACTIONATION194
6.8.1PROTEIN FRACTIONATION TO ENABLE EFFECTIVE SEPARATION OF THOUSANDS OF PROTEINS IN COMPLEX MIXTURES194
TABLE 141PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY REGION, 2021–2028 (USD MILLION)195
TABLE 142NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021–2028 (USD MILLION)195
TABLE 143EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021–2028 (USD MILLION)196
TABLE 144ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021–2028 (USD MILLION)196
TABLE 145LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021–2028 (USD MILLION)197
6.9OTHER TECHNOLOGIES197
TABLE 146PROTEOMICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION)198
TABLE 147NORTH AMERICA: PROTEOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)198
TABLE 148EUROPE: PROTEOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)199
TABLE 149ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)199
TABLE 150LATIN AMERICA: PROTEOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)200
7PROTEOMICS MARKET, BY REAGENT201
7.1INTRODUCTION202
TABLE 151PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION)202
7.2IMMUNOASSAY REAGENTS202
7.2.1IMMUNOASSAY REAGENTS TO DOMINATE PROTEOMICS MARKET DURING FORECAST PERIOD202
TABLE 152PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY REGION, 2021–2028 (USD MILLION)204
TABLE 153NORTH AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)204
TABLE 154EUROPE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)205
TABLE 155ASIA PACIFIC: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)205
TABLE 156LATIN AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)206
7.3SPECTROSCOPY REAGENTS206
7.3.1INCREASED ADOPTION OF MS-BASED APPROACHES IN PROTEOMICS TO DRIVE MARKET206
TABLE 157PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY REGION, 2021–2028 (USD MILLION)207
TABLE 158NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)207
TABLE 159EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)208
TABLE 160ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)208
TABLE 161LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)209
7.4CHROMATOGRAPHY REAGENTS209
7.4.1INCREASING DEMAND FOR PROTEIN PURIFICATION TO AID MARKET209
TABLE 162PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY REGION, 2021–2028 (USD MILLION)210
TABLE 163NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)210
TABLE 164EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)211
TABLE 165ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)211
TABLE 166LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)212
7.5PROTEIN MICROARRAY REAGENTS212
7.5.1INCREASED FOCUS ON ANALYZING PROTEIN INTERACTIONS TO INCREASE USE OF PROTEIN MICROARRAY REAGENTS212
TABLE 167PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY REGION, 2021–2028 (USD MILLION)213
TABLE 168NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)213
TABLE 169EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)214
TABLE 170ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)214
TABLE 171LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)215
7.6X-RAY CRYSTALLOGRAPHY REAGENTS215
7.6.1X-RAY CRYSTALLOGRAPHY TO BE ESSENTIAL IN PROTEIN STRUCTURE DETERMINATION215
TABLE 172PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY REGION, 2021–2028 (USD MILLION)216
TABLE 173NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)216
TABLE 174EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)217
TABLE 175ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)217
TABLE 176LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)218
7.7ELECTROPHORESIS REAGENTS218
7.7.1INCREASING DEMAND FOR 2D ELECTROPHORESIS TO PROPEL MARKET218
TABLE 177PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY REGION, 2021–2028 (USD MILLION)219
TABLE 178NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)219
TABLE 179EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)220
TABLE 180ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)220
TABLE 181LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)221
7.8PROTEIN FRACTIONATION REAGENTS221
7.8.1INCREASING NEED FOR PROTEIN SEPARATION FROM COMPLEX MIXTURES TO AUGMENT MARKET221
TABLE 182PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY REGION, 2021–2028 (USD MILLION)222
TABLE 183NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)222
TABLE 184EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)223
TABLE 185ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)223
TABLE 186LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)224
7.9OTHER REAGENTS224
TABLE 187PROTEOMICS MARKET FOR OTHER REAGENTS, BY REGION, 2021–2028 (USD MILLION)225
TABLE 188NORTH AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)225
TABLE 189EUROPE: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)226
TABLE 190ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)226
TABLE 191LATIN AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)227
8PROTEOMICS MARKET, BY SERVICE & SOFTWARE228
8.1INTRODUCTION229
TABLE 192PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)229
8.2CORE PROTEOMICS SERVICES229
TABLE 193PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)230
TABLE 194PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY REGION, 2021–2028 (USD MILLION)230
TABLE 195NORTH AMERICA: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)231
TABLE 196EUROPE: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)231
TABLE 197ASIA PACIFIC: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)232
TABLE 198LATIN AMERICA: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)232
8.2.1PROTEIN IDENTIFICATION SERVICES232
8.2.1.1Rising demand for molecular weight analysis to boost market growth232
TABLE 199PROTEIN IDENTIFICATION SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)234
TABLE 200NORTH AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)234
TABLE 201EUROPE: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)235
TABLE 202ASIA PACIFIC: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)235
TABLE 203LATIN AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)236
8.2.2PROTEIN CHARACTERIZATION SERVICES236
8.2.2.1Increased focus on study of complex protein structure, drug development, and PTMs to drive segment236
TABLE 204PROTEIN CHARACTERIZATION SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)237
TABLE 205NORTH AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2021–2028 (USD MILLION)237
TABLE 206EUROPE: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2021–2028 (USD MILLION)238
TABLE 207ASIA PACIFIC: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)238
TABLE 208LATIN AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2021–2028 (USD MILLION)239
8.2.3QUANTITATIVE PROTEOMICS SERVICES239
8.2.3.1Quantitative proteomics to be critical for understanding protein expression and modifications239
TABLE 209QUANTITATIVE PROTEOMICS SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)240
TABLE 210NORTH AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)241
TABLE 211EUROPE: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)241
TABLE 212ASIA PACIFIC: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)242
TABLE 213LATIN AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)242
8.2.4PROTEIN PURIFICATION SERVICES242
8.2.4.1Protein purification services to improve overall proteome analysis242
TABLE 214PROTEIN PURIFICATION SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)243
TABLE 215NORTH AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)244
TABLE 216EUROPE: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)244
TABLE 217ASIA PACIFIC: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)245
TABLE 218LATIN AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)245
8.2.5PROTEIN SEPARATION SERVICES245
8.2.5.1Protein separation services to characterize large-sized proteomes of different sizes245
TABLE 219PROTEIN SEPARATION SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)246
TABLE 220NORTH AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)247
TABLE 221EUROPE: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)247
TABLE 222ASIA PACIFIC: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)248
TABLE 223LATIN AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)248
8.2.6PROTEIN SEQUENCING SERVICES248
8.2.6.1Identification and characterization of post-translational modifications to determine characterizations of proteins248
TABLE 224PROTEIN SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)250
TABLE 225NORTH AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)250
TABLE 226EUROPE: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)251
TABLE 227ASIA PACIFIC: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)251
TABLE 228LATIN AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)252
8.2.7CUSTOM ASSAY SERVICES252
8.2.7.1Custom assays to improve validation or consistency of protein analysis procedures252
TABLE 229CUSTOM ASSAY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)253
TABLE 230NORTH AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)253
TABLE 231EUROPE: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)254
TABLE 232ASIA PACIFIC: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)254
TABLE 233LATIN AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)255
8.3BIOINFORMATICS SOFTWARE & SERVICES255
TABLE 234PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)256
8.3.1BIOINFORMATICS SERVICES256
8.3.1.1Bioinformatics services to dominate proteomics market during study period256
TABLE 235BIOINFORMATICS SERVICES MARKET, BY REGION, 2021–202
“The spectroscopy segment is likely to grow at the highest CAGR during the forecast period of 2023-2028.”
On the basis of instrumentation technologies, the proteomics market is broadly segmented into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, protein fractionation, and other technologies. The spectroscopy segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to the factor that the technique is widely employed in protein analysis to elucidate the protein structure (size, shape, secondary, or tertiary conformations), quantification, and interactions with molecules such as ligands, solutes, or other proteins.
“The biochips sub-segment is likely to grow at the highest CAGR during the forecast period of 2023-2028.”
On the basis of instrumentation technology protein microarray, the proteomics market is broadly segmented into biochips and microarray instruments. The biochips segment is projected to grow at the highest CAGR during the forecast period. The growth is attributed to the several advantages in proteomics research, including high-throughput analysis, multiplexing, sensitivity, specificity, reduced sample requirements, and automation.
“The pharmaceutical & biotechnological companies segment is likely to grow at the highest CAGR during the forecast period of 2023-2028.”
Based on end users, the proteomics market is segmented into hospitals, clinical laboratories, pharmaceutical companies, academic research laboratories, and other end users like CDMOs, and CROs. The pharmaceutical & biotechnological companies segment held a dominant share of the proteomics market, in 2022. The large share of this segment is attributed to the growing focus of pharma giants on core activities like increasing R&D for the discovery & development of new molecules. This is one of the major factors anticipated to project market growth.
“Asia Pacific region is likely to grow at a faster pace.”
The proteomics market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of the proteomics market. The dominance of the region is attributable to various factors such as the presence of leading players in the region coupled with the ongoing research activities of developing new targeted therapies. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the growing awareness of personalized therapeutics, rising government initiatives for generic medicines in the region, and the emergence of new market players in the proteomics market.
The primary interviews conducted for this report can be categorized as follows:
•By Respondent: Supply Side- 70%, and Demand Side - 30%
•By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
•By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%
Lists of Companies Profiled in the Report:
•Thermo Fisher Scientific, Inc. (US)
•Agilent Technologies, Inc. (US)
•Merck KGaA (Germany)
•Danaher Corporation (US)
•Waters Corporation (US)
•Bio-Rad Laboratories, Inc. (US)
•Bruker Corporation (US)
•PerkinElmer Inc. (US)
•Shimadzu Corporation (Japan)
•Illumina, Inc. (US)
•Promega Corporation (US)
•Eurofins Scientific (Luxembourg)
•QIAGEN N.V. (Germany)
•Charles River Laboratories (US)
•Protagene Protein Services (Germany)
•Creative Proteomics (US)
•HORIBA Corporation (Japan)
•Sengenics (Singapore)
•Biomax Informatics AG (Germany)
•WuXi NextCode (China)
•FIOS Genomics (UK)
•Genewiz (US)
•Medgenome Labs (India)
•Biognosys AG (Switzerland)
•Macrogen Inc. (South Korea)
Research Coverage:
This report provides a detailed picture of the proteomics market. It aims at estimating the size and future growth potential of the market across different segments, such as instrumentation technologies, reagents, software & services, application, end user, and regions. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall proteomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
•Analysis of key drivers (Increasing demand for personalized medicines for clinical practices, Rising incidences of chronic diseases among geriatric population, Increased investments in research and greater adoption of proteomics in drug discovery, Technological advancements in proteomics), restraints (High costs of proteomics instruments and technologies, Lack of standardization in proteomics workflow among research groups), opportunities (High growth opportunities for proteomics research in emerging countries, Growing prominence of nano proteomics in biological processes), and challenges (Low biomarker discovery to approval ratio in proteomics research, Lack of data management/handling in proteomics research) influencing the growth of proteomics market.
•Product & Service Development/Innovation: Detailed insights on newly launched products, and technological assessment of the proteomics market.
•Market Development: Comprehensive information about lucrative markets – the report analyses the proteomics market across varied regions.
•Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the proteomics market.
•Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of leading players like Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), and Waters Corporation (US) and among others in the proteomics market.
1INTRODUCTION70
1.1STUDY OBJECTIVES70
1.2MARKET DEFINITION AND SCOPE70
1.2.1INCLUSIONS AND EXCLUSIONS71
1.2.2MARKETS COVERED72
1.2.3YEARS CONSIDERED73
1.3CURRENCY CONSIDERED73
1.4STAKEHOLDERS73
1.5RESEARCH LIMITATIONS74
1.6SUMMARY OF CHANGES74
1.7RECESSION IMPACT75
2RESEARCH METHODOLOGY76
2.1RESEARCH DATA76
FIGURE 1RESEARCH DESIGN76
2.1.1SECONDARY DATA77
2.1.2PRIMARY DATA78
FIGURE 2PROTEOMICS MARKET: BREAKDOWN OF PRIMARIES78
2.2MARKET SIZE ESTIMATION79
FIGURE 3PROTEOMICS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 202279
FIGURE 4MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 202280
FIGURE 5ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 202280
2.2.1INSIGHTS FROM PRIMARIES82
FIGURE 6MARKET VALIDATION FROM PRIMARY EXPERTS82
2.2.2SEGMENT ASSESSMENT (BY PRODUCT, SOFTWARE & SERVICE, AND END USER)82
FIGURE 7MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH82
2.3GROWTH RATE ASSUMPTIONS83
FIGURE 8PROTEOMICS MARKET: CAGR PROJECTIONS, 2023–202884
FIGURE 9PROTEOMICS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES84
2.4MARKET BREAKDOWN AND DATA TRIANGULATION85
FIGURE 10DATA TRIANGULATION METHODOLOGY85
2.5STUDY ASSUMPTIONS86
2.6RISK ANALYSIS86
2.7IMPACT OF ECONOMIC RECESSION ON PROTEOMICS MARKET86
TABLE 1GLOBAL INFLATION RATE PROJECTIONS, 2024–2027 (% GROWTH)87
TABLE 2US HEALTH EXPENDITURE, 2019–2027 (USD MILLION)87
TABLE 3US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)87
3EXECUTIVE SUMMARY88
FIGURE 11PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2023 VS. 2028 (USD MILLION)88
FIGURE 12PROTEOMICS MARKET, BY REAGENT, 2023 VS. 2028 (USD MILLION)89
FIGURE 13PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2023 VS. 2028 (USD MILLION)90
FIGURE 14PROTEOMICS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)90
FIGURE 15PROTEOMICS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)91
FIGURE 16GEOGRAPHICAL SNAPSHOT OF PROTEOMICS MARKET92
4PREMIUM INSIGHTS93
4.1OVERVIEW OF PROTEOMICS MARKET93
FIGURE 17RISING INVESTMENTS IN PHARMACEUTICAL R&D TO DRIVE MARKET93
4.2NORTH AMERICA: PROTEOMICS MARKET SHARE, BY APPLICATION AND COUNTRY (2022)94
FIGURE 18CLINICAL DIAGNOSTICS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PROTEOMICS MARKET IN 202294
4.3ELECTROPHORESIS MARKET SHARE, BY TYPE, 2023 VS. 2028 (USD MILLION)95
FIGURE 19GEL ELECTROPHORESIS TO DOMINATE MARKET IN 202895
4.4PROTEOMICS MARKET SHARE, BY END USER (2022)95
FIGURE 20PHARMACEUTICAL COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 202295
4.5PROTEOMICS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES96
FIGURE 21ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN PROTEOMICS MARKET DURING STUDY PERIOD96
5MARKET OVERVIEW97
5.1INTRODUCTION97
5.2MARKET DYNAMICS97
FIGURE 22PROTEOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES97
TABLE 4PROTEOMICS MARKET: IMPACT ANALYSIS98
5.2.1DRIVERS98
5.2.1.1Increasing demand for personalized medicines for clinical practices98
FIGURE 23PERSONALIZED MEDICINES APPROVED BY FDA, 2015–202299
5.2.1.2Rising incidences of chronic diseases among geriatric population100
5.2.1.3Increased investments in research and greater adoption of proteomics in drug discovery100
FIGURE 24GLOBAL SPENDING ON PHARMACEUTICAL R&D, 2015–2028 (USD BILLION)101
5.2.1.4Technological advancements in proteomics101
5.2.2RESTRAINTS102
5.2.2.1High costs of proteomics instruments and technologies102
5.2.2.2Lack of standardization in proteomics workflow among research groups103
5.2.3OPPORTUNITIES103
5.2.3.1High growth opportunities for proteomics research in emerging countries103
5.2.3.2Growing prominence of nano proteomics in biological processes104
5.2.4CHALLENGES105
5.2.4.1Low biomarker discovery to approval ratio in proteomics research105
5.2.4.2Lack of data management/handling in proteomics research105
5.3VALUE CHAIN ANALYSIS106
FIGURE 25VALUE CHAIN ANALYSIS: MANUFACTURING AND DISTRIBUTION PHASES PROVIDE MAXIMUM VALUE106
5.4SUPPLY CHAIN ANALYSIS107
FIGURE 26PROTEOMICS MARKET: SUPPLY CHAIN ANALYSIS107
5.5ECOSYSTEM ANALYSIS108
FIGURE 27ECOSYSTEM ANALYSIS: PROTEOMICS MARKET108
TABLE 5PROTEOMICS MARKET: ROLE IN ECOSYSTEM109
5.6PORTER’S FIVE FORCES ANALYSIS109
TABLE 6PROTEOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS109
5.6.1THREAT OF NEW ENTRANTS109
5.6.2THREAT OF SUBSTITUTES110
5.6.3BARGAINING POWER OF SUPPLIERS110
5.6.4BARGAINING POWER OF BUYERS110
5.6.5INTENSITY OF COMPETITIVE RIVALRY110
5.7PATENT ANALYSIS111
5.8PRICING ANALYSIS111
TABLE 7AVERAGE SELLING PRICE OF PROTEOMICS PRODUCTS (2022)111
TABLE 8PERKINELMER: SELLING PRICE OF VARIOUS PRODUCTS/SERVICES112
TABLE 9MERCK: SELLING PRICE OF VARIOUS PRODUCTS/SERVICES112
5.9TECHNOLOGY ANALYSIS113
TABLE 10COMPARISON OF MODERN PROTEOMICS ANALYSIS METHODS113
TABLE 11COMMONLY USED BIOINFORMATICS TOOLS IN PROTEOMICS114
TABLE 12TECHNOLOGIES LAUNCHED RECENTLY IN PROTEOMICS114
5.10REGULATORY ANALYSIS115
5.10.1REGULATIONS FOR PRODUCTS DEVELOPED USING PROTEOMICS TECHNIQUES115
TABLE 13KEY REGULATORY GUIDELINES FOR PROTEOMICS PRODUCTS116
5.10.2REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS116
TABLE 14NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS116
TABLE 15EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS117
TABLE 16ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS117
5.11KEY CONFERENCES AND EVENTS IN 2023118
TABLE 17PROTEOMICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023118
5.12KEY STAKEHOLDERS AND BUYING CRITERIA119
5.12.1KEY STAKEHOLDERS IN BUYING PROCESS119
FIGURE 28INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR APPLICATIONS119
TABLE 18INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR APPLICATIONS119
5.12.2BUYING CRITERIA119
FIGURE 29KEY BUYING CRITERIA FOR END USERS119
5.13TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES120
5.14TRADE ANALYSIS120
5.14.1TRADE ANALYSIS FOR ELECTROPHORESIS AND CHROMATOGRAPHY INSTRUMENTS120
TABLE 19IMPORT DATA FOR ELECTROPHORESIS AND CHROMATOGRAPHY INSTRUMENTS, BY COUNTRY, 2017–2021 (USD MILLION)120
5.14.2TRADE ANALYSIS FOR DIAGNOSTICS AND LABORATORY REAGENTS121
TABLE 20IMPORT DATA FOR DIAGNOSTICS AND CLINICAL REAGENTS, BY COUNTRY, 2017–2021 (USD MILLION)121
TABLE 21EXPORT DATA FOR DIAGNOSTICS AND CLINICAL REAGENTS, BY COUNTRY, 2017–2021 (TONS)121
5.14.3TRADE ANALYSIS FOR IMMUNOASSAYS121
TABLE 22IMPORT DATA FOR HS CODE 902750, BY COUNTRY, 2017–2021 (USD MILLION)121
6PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY122
6.1INTRODUCTION123
6.1.1PRICING ANALYSIS123
TABLE 23AVERAGE SELLING PRICE OF PRODUCTS AND SERVICES, 2022 (USD)123
TABLE 24PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)124
6.2SPECTROSCOPY124
TABLE 25PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)125
TABLE 26PROTEOMICS MARKET FOR SPECTROSCOPY, BY REGION, 2021–2028 (USD MILLION)125
TABLE 27NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)126
TABLE 28EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)126
TABLE 29ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)127
TABLE 30LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)127
6.2.1MASS SPECTROSCOPY128
6.2.1.1High specificity of mass spectroscopy to boost market128
TABLE 31MASS SPECTROSCOPY MARKET, BY REGION, 2021–2028 (USD MILLION)129
TABLE 32NORTH AMERICA: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)129
TABLE 33EUROPE: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)130
TABLE 34ASIA PACIFIC: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)130
TABLE 35LATIN AMERICA: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)131
6.2.2NMR SPECTROSCOPY131
6.2.2.1NMR experiments to evaluate physical, chemical, electronic, and structural information of proteins131
TABLE 36NMR SPECTROSCOPY MARKET, BY REGION, 2021–2028 (USD MILLION)132
TABLE 37NORTH AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)132
TABLE 38EUROPE: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)133
TABLE 39ASIA PACIFIC: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)133
TABLE 40LATIN AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)134
6.2.3CD SPECTROSCOPY134
6.2.3.1CD spectroscopy to examine changes in secondary structures of protein in response to environmental conditions134
TABLE 41CD SPECTROSCOPY MARKET, BY REGION, 2021–2028 (USD MILLION)135
TABLE 42NORTH AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)135
TABLE 43EUROPE: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)136
TABLE 44ASIA PACIFIC: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)136
TABLE 45LATIN AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)137
6.3CHROMATOGRAPHY137
TABLE 46PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)138
TABLE 47PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY REGION, 2021–2028 (USD MILLION)138
TABLE 48NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)139
TABLE 49EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)139
TABLE 50ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)140
TABLE 51LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)140
6.3.1HPLC141
6.3.1.1Growing biopharmaceutical industry and increasing investments in life science research141
TABLE 52HPLC MARKET, BY REGION, 2021–2028 (USD MILLION)142
TABLE 53NORTH AMERICA: HPLC MARKET, BY COUNTRY, 2021–2028 (USD MILLION)142
TABLE 54EUROPE: HPLC MARKET, BY COUNTRY, 2021–2028 (USD MILLION)143
TABLE 55ASIA PACIFIC: HPLC MARKET, BY COUNTRY, 2021–2028 (USD MILLION)143
TABLE 56LATIN AMERICA: HPLC MARKET, BY COUNTRY, 2021–2028 (USD MILLION)144
6.3.2ION CHROMATOGRAPHY144
6.3.2.1Ion chromatography to be most significant chromatographic technique for separation and purification of proteins144
TABLE 57ION CHROMATOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)145
TABLE 58NORTH AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)145
TABLE 59EUROPE: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)146
TABLE 60ASIA PACIFIC: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)146
TABLE 61LATIN AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)147
6.3.3AFFINITY CHROMATOGRAPHY147
6.3.3.1Affinity chromatography to quantify protein expression using isotope-coded affinity tags147
TABLE 62AFFINITY CHROMATOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)148
TABLE 63NORTH AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)148
TABLE 64EUROPE: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)149
TABLE 65ASIA PACIFIC: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)149
TABLE 66LATIN AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)150
6.3.4SUPERCRITICAL FLUID CHROMATOGRAPHY150
6.3.4.1Supercritical fluid chromatography to separate complex protein mixtures with high efficiency and speed150
TABLE 67SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)151
TABLE 68NORTH AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)151
TABLE 69EUROPE: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)152
TABLE 70ASIA PACIFIC: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)152
TABLE 71LATIN AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)153
6.4ELECTROPHORESIS153
TABLE 72PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)154
TABLE 73PROTEOMICS MARKET FOR ELECTROPHORESIS, BY REGION, 2021–2028 (USD MILLION)154
TABLE 74NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION)155
TABLE 75EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION)155
TABLE 76ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION)156
TABLE 77LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION)156
6.4.1GEL ELECTROPHORESIS157
6.4.1.1Increasing demand for gel electrophoresis in proteomics research and personalized medicine157
TABLE 78GEL ELECTROPHORESIS MARKET, BY REGION, 2021–2028 (USD MILLION)157
TABLE 79NORTH AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)158
TABLE 80EUROPE: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)158
TABLE 81ASIA PACIFIC: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)159
TABLE 82LATIN AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)159
6.4.2CAPILLARY ELECTROPHORESIS160
6.4.2.1Rise in applications of capillary electrophoresis in therapeutics and drug discovery160
TABLE 83CAPILLARY ELECTROPHORESIS MARKET, BY REGION, 2021–2028 (USD MILLION)161
TABLE 84NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)161
TABLE 85EUROPE: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)162
TABLE 86ASIA PACIFIC: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)162
TABLE 87LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)163
6.5PROTEIN MICROARRAYS163
TABLE 88PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)164
TABLE 89PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY REGION, 2021–2028 (USD MILLION)164
TABLE 90NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)165
TABLE 91EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)165
TABLE 92ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)166
TABLE 93LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)166
6.5.1BIOCHIPS166
TABLE 94BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)167
TABLE 95BIOCHIPS MARKET, BY REGION, 2021–2028 (USD MILLION)167
TABLE 96NORTH AMERICA: BIOCHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)168
TABLE 97EUROPE: BIOCHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)168
TABLE 98ASIA PACIFIC: BIOCHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)169
TABLE 99LATIN AMERICA: BIOCHIPS MARKET, BY REGION, 2021–2028 (USD MILLION)169
6.5.1.1Lab-on-chips169
6.5.1.1.1Rising applications of lab-on-chips in microfabrication and nanotechnology development169
TABLE 100LAB-ON-CHIPS MARKET, BY REGION, 2021–2028 (USD MILLION)170
TABLE 101NORTH AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)171
TABLE 102EUROPE: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)171
TABLE 103ASIA PACIFIC: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)172
TABLE 104LATIN AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)172
6.5.1.2Protein chips173
6.5.1.2.1Competitive advantage over conventional protein analysis tools173
TABLE 105PROTEIN CHIPS MARKET, BY REGION, 2021–2028 (USD MILLION)174
TABLE 106NORTH AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)174
TABLE 107EUROPE: PROTEIN CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)175
TABLE 108ASIA PACIFIC: PROTEIN CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)175
TABLE 109LATIN AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)176
6.5.2MICROARRAY INSTRUMENTS176
TABLE 110MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)177
TABLE 111MICROARRAY INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)177
TABLE 112NORTH AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)178
TABLE 113EUROPE: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)178
TABLE 114ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)179
TABLE 115LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)179
6.5.2.1Integrated systems180
6.5.2.1.1Integrated systems to enable high-throughput and reproducible analysis of large numbers of proteins180
TABLE 116INTEGRATED SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)180
TABLE 117NORTH AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)181
TABLE 118EUROPE: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)181
TABLE 119ASIA PACIFIC: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)182
TABLE 120LATIN AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)182
6.5.2.2Microarray scanners183
6.5.2.2.1Microarray scanners to provide high-quality analysis and cost efficiency183
TABLE 121MICROARRAY SCANNERS MARKET, BY REGION, 2021–2028 (USD MILLION)183
TABLE 122NORTH AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)184
TABLE 123EUROPE: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)184
TABLE 124ASIA PACIFIC: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)185
TABLE 125LATIN AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)185
6.5.2.3Arrayers186
6.5.2.3.1Technological advancements to make microarray spotters ideal for large-scale arraying projects186
TABLE 126ARRAYERS MARKET, BY REGION, 2021–2028 (USD MILLION)186
TABLE 127NORTH AMERICA: ARRAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)186
TABLE 128EUROPE: ARRAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)187
TABLE 129ASIA PACIFIC: ARRAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)187
TABLE 130LATIN AMERICA: ARRAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)188
6.6X-RAY CRYSTALLOGRAPHY188
6.6.1INCREASED NEED FOR HIGH-RESOLUTION INFORMATION ON PROTEIN STRUCTURES WITH X-RAY CRYSTALLOGRAPHY TO AID MARKET188
TABLE 131PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY REGION, 2021–2028 (USD MILLION)189
TABLE 132NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)189
TABLE 133EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)190
TABLE 134ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)190
TABLE 135LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)191
6.7SURFACE PLASMON RESONANCE191
6.7.1ABILITY TO MEASURE BINDING AFFINITIES AND KINETICS OF COMPLEXES TO PROPEL MARKET191
TABLE 136PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY REGION, 2021–2028 (USD MILLION)192
TABLE 137NORTH AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION)192
TABLE 138EUROPE: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION)193
TABLE 139ASIA PACIFIC: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION)193
TABLE 140LATIN AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION)194
6.8PROTEIN FRACTIONATION194
6.8.1PROTEIN FRACTIONATION TO ENABLE EFFECTIVE SEPARATION OF THOUSANDS OF PROTEINS IN COMPLEX MIXTURES194
TABLE 141PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY REGION, 2021–2028 (USD MILLION)195
TABLE 142NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021–2028 (USD MILLION)195
TABLE 143EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021–2028 (USD MILLION)196
TABLE 144ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021–2028 (USD MILLION)196
TABLE 145LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021–2028 (USD MILLION)197
6.9OTHER TECHNOLOGIES197
TABLE 146PROTEOMICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION)198
TABLE 147NORTH AMERICA: PROTEOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)198
TABLE 148EUROPE: PROTEOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)199
TABLE 149ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)199
TABLE 150LATIN AMERICA: PROTEOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)200
7PROTEOMICS MARKET, BY REAGENT201
7.1INTRODUCTION202
TABLE 151PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION)202
7.2IMMUNOASSAY REAGENTS202
7.2.1IMMUNOASSAY REAGENTS TO DOMINATE PROTEOMICS MARKET DURING FORECAST PERIOD202
TABLE 152PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY REGION, 2021–2028 (USD MILLION)204
TABLE 153NORTH AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)204
TABLE 154EUROPE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)205
TABLE 155ASIA PACIFIC: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)205
TABLE 156LATIN AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)206
7.3SPECTROSCOPY REAGENTS206
7.3.1INCREASED ADOPTION OF MS-BASED APPROACHES IN PROTEOMICS TO DRIVE MARKET206
TABLE 157PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY REGION, 2021–2028 (USD MILLION)207
TABLE 158NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)207
TABLE 159EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)208
TABLE 160ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)208
TABLE 161LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)209
7.4CHROMATOGRAPHY REAGENTS209
7.4.1INCREASING DEMAND FOR PROTEIN PURIFICATION TO AID MARKET209
TABLE 162PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY REGION, 2021–2028 (USD MILLION)210
TABLE 163NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)210
TABLE 164EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)211
TABLE 165ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)211
TABLE 166LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)212
7.5PROTEIN MICROARRAY REAGENTS212
7.5.1INCREASED FOCUS ON ANALYZING PROTEIN INTERACTIONS TO INCREASE USE OF PROTEIN MICROARRAY REAGENTS212
TABLE 167PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY REGION, 2021–2028 (USD MILLION)213
TABLE 168NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)213
TABLE 169EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)214
TABLE 170ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)214
TABLE 171LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)215
7.6X-RAY CRYSTALLOGRAPHY REAGENTS215
7.6.1X-RAY CRYSTALLOGRAPHY TO BE ESSENTIAL IN PROTEIN STRUCTURE DETERMINATION215
TABLE 172PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY REGION, 2021–2028 (USD MILLION)216
TABLE 173NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)216
TABLE 174EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)217
TABLE 175ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)217
TABLE 176LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)218
7.7ELECTROPHORESIS REAGENTS218
7.7.1INCREASING DEMAND FOR 2D ELECTROPHORESIS TO PROPEL MARKET218
TABLE 177PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY REGION, 2021–2028 (USD MILLION)219
TABLE 178NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)219
TABLE 179EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)220
TABLE 180ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)220
TABLE 181LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)221
7.8PROTEIN FRACTIONATION REAGENTS221
7.8.1INCREASING NEED FOR PROTEIN SEPARATION FROM COMPLEX MIXTURES TO AUGMENT MARKET221
TABLE 182PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY REGION, 2021–2028 (USD MILLION)222
TABLE 183NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)222
TABLE 184EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)223
TABLE 185ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)223
TABLE 186LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)224
7.9OTHER REAGENTS224
TABLE 187PROTEOMICS MARKET FOR OTHER REAGENTS, BY REGION, 2021–2028 (USD MILLION)225
TABLE 188NORTH AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)225
TABLE 189EUROPE: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)226
TABLE 190ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)226
TABLE 191LATIN AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)227
8PROTEOMICS MARKET, BY SERVICE & SOFTWARE228
8.1INTRODUCTION229
TABLE 192PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)229
8.2CORE PROTEOMICS SERVICES229
TABLE 193PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)230
TABLE 194PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY REGION, 2021–2028 (USD MILLION)230
TABLE 195NORTH AMERICA: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)231
TABLE 196EUROPE: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)231
TABLE 197ASIA PACIFIC: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)232
TABLE 198LATIN AMERICA: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)232
8.2.1PROTEIN IDENTIFICATION SERVICES232
8.2.1.1Rising demand for molecular weight analysis to boost market growth232
TABLE 199PROTEIN IDENTIFICATION SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)234
TABLE 200NORTH AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)234
TABLE 201EUROPE: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)235
TABLE 202ASIA PACIFIC: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)235
TABLE 203LATIN AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)236
8.2.2PROTEIN CHARACTERIZATION SERVICES236
8.2.2.1Increased focus on study of complex protein structure, drug development, and PTMs to drive segment236
TABLE 204PROTEIN CHARACTERIZATION SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)237
TABLE 205NORTH AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2021–2028 (USD MILLION)237
TABLE 206EUROPE: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2021–2028 (USD MILLION)238
TABLE 207ASIA PACIFIC: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)238
TABLE 208LATIN AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2021–2028 (USD MILLION)239
8.2.3QUANTITATIVE PROTEOMICS SERVICES239
8.2.3.1Quantitative proteomics to be critical for understanding protein expression and modifications239
TABLE 209QUANTITATIVE PROTEOMICS SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)240
TABLE 210NORTH AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)241
TABLE 211EUROPE: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)241
TABLE 212ASIA PACIFIC: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)242
TABLE 213LATIN AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)242
8.2.4PROTEIN PURIFICATION SERVICES242
8.2.4.1Protein purification services to improve overall proteome analysis242
TABLE 214PROTEIN PURIFICATION SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)243
TABLE 215NORTH AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)244
TABLE 216EUROPE: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)244
TABLE 217ASIA PACIFIC: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)245
TABLE 218LATIN AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)245
8.2.5PROTEIN SEPARATION SERVICES245
8.2.5.1Protein separation services to characterize large-sized proteomes of different sizes245
TABLE 219PROTEIN SEPARATION SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)246
TABLE 220NORTH AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)247
TABLE 221EUROPE: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)247
TABLE 222ASIA PACIFIC: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)248
TABLE 223LATIN AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)248
8.2.6PROTEIN SEQUENCING SERVICES248
8.2.6.1Identification and characterization of post-translational modifications to determine characterizations of proteins248
TABLE 224PROTEIN SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)250
TABLE 225NORTH AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)250
TABLE 226EUROPE: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)251
TABLE 227ASIA PACIFIC: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)251
TABLE 228LATIN AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)252
8.2.7CUSTOM ASSAY SERVICES252
8.2.7.1Custom assays to improve validation or consistency of protein analysis procedures252
TABLE 229CUSTOM ASSAY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)253
TABLE 230NORTH AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)253
TABLE 231EUROPE: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)254
TABLE 232ASIA PACIFIC: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)254
TABLE 233LATIN AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)255
8.3BIOINFORMATICS SOFTWARE & SERVICES255
TABLE 234PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)256
8.3.1BIOINFORMATICS SERVICES256
8.3.1.1Bioinformatics services to dominate proteomics market during study period256
TABLE 235BIOINFORMATICS SERVICES MARKET, BY REGION, 2021–202
Related Report
